Cannabis Can Prevent Cancer Caused By Cigarette Use, According To New Study

tobacco cigarettes marijuana cannabis

“A new study published by the journal J-Stage, and funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan, has found that cannabinoids – whether THC, CBD or CBDV – were effective at blocking a certain enzyme which is known to cause cancer, and is produced in large amount when cigarettes are consumed.”

“These results suggest that the pentylresorcinol structure in CBD may have structurally important roles in direct CYP1A1 inhibition, although the whole structure of CBD is required for overall inhibition”, according to researchers.

CYP1A1 is an enzyme which isn’t dangerous at low-levels, but is produced in large quantities when someone smokes cigarettes; at large doses, the enzyme has been linked to cancer.

Researchers state that; “Accordingly, CBD and its related compounds, which are potent inhibitors of CYP1A1 activity, would be useful as a lead compound in anticancer chemotherapy.””

http://www.theweedblog.com/cannabis-can-prevent-cancer-caused-by-cigarette-use-according-to-new-study/

“Marijuana Disrupts Cancer Pathway of Cigarettes: Study” http://www.truthonpot.com/2013/08/19/marijuana-disrupts-cancer-pathway-of-cigarettes-study/

Chemicals in marijuana block the activity of a cancer-causing enzyme present in cigarette smokers.
 
“Chemicals in marijuana can block the activity of a cancer-causing enzyme commonly found in cigarette smokers.”
 
 

“Cannabis Can Prevent Cancer Caused by Cigarette Use, According to New Study” http://thejointblog.com/cannabis-can-prevent-cancer-caused-by-cigarrette-use-according-to-new-study/ 

“Marijuana Can Prevent Millions of Tobacco Deaths” http://salem-news.com/articles/august122013/tobacco-marijuanapl.php

Cannabinoid receptors as a target for therapy of ovarian cancer

“Ovarian cancer represents one of the leading cause of cancer-relateddeaths for women and is the most common gynecologic malignancy.In spite of relative low morbidity, ovarian cancer has a highfatality ratio, with overall 5-year survival of less than 30%.At present, there are inadequate treatment options for the managementof advanced ovarian cancer, and therefore development of novelapproaches for treatment of this disease are needed.

Cannabinoids,the active components of Cannabis sativa linnaeous and their derivatives have received considerable attention in recent yearsdue to their diverse pharmacological activities such as cell growth inhibition and tumor regression. To date, two differentcannabinoid receptors have been characterized and cloned frommammalian tissues: the “central” CB1 receptor and the “peripheral”CB2 receptor…

These results support a new therapeutic approach for the treatmentof ovarian cancer. It is also conceivable that with available cannabinoids as lead compounds, non-habit forming agents that have higher biological effects could be developed.”

http://www.aacrmeetingabstracts.org/cgi/content/abstract/2006/1/1084

http://cancerres.aacrjournals.org/content/66/8_Supplement/1084.1

Active Ingredient in Marijuana Kills Brain Cancer Cells

“New research out of Spain suggests that THC — the active ingredient in marijuana — appears to prompt the death of brain cancer cells.”

 
“The finding is based on work with mice designed to carry human cancer tumors, as well as from an analysis of THC’s impact on tumor cells extracted from two patients coping with a highly aggressive form of brain cancer.”
 

THC is anticarcinogenic: marijuana may be cancer cure!

“Toxicology and Carcinogenesis Studies of 1-Trans-[Delta.sup.9]-Tetrahydrocannabinol

Summation of above:

“Thus, in our studies, rats and mice that received THC for 2 years exhibited body weight reductions, enhanced survival rates, and decreased tumor incidences in several sites, mainly organs under hormonal control. These earlier experimental carcinogenesis results on THC clearly lend further validity to the notion that cannabinoids may indeed be anticarcinogenic.””

 link
http://www.thefreelibrary.com/Antitumor+Effects+of+THC-a06814…

http://www.sodahead.com/united-states/thc-is-anticarcinogenic-marijuana-may-be-cancer-cure/question-1031413/?link=ibaf&q=THC+anti-carcinogenic+news

Curing Cancer with Cannabis

“Repeal Archaic Anti-Marijuana Laws”

cannabis
“Although cannabis has been used in medical treatment for thousands of years in China and India, it became illegal in most of the western world in the first half of the twentieth century. This was thanks to an early corporate conspiracy involving DuPont, William Randolph Hearst, the Mellon Bank and Secretary of the Treasury Andrew Mellon. The major problem with hemp was its immense versatility. Most paper and nearly all plastics were made of hemp fiber, while hemp oil was a major fuel. Dupont was trying to promote their own petroleum-based plastic, Hearst his wood pulp paper factories, and Mellon his friends at Standard Oil. See The Politics of Hemp.

Recent research, mainly out of Spain and Italy (such research is  illegal in the US), reveals that treatment with a cannabis metabolite cannobidiol (CBD) has a marked effect on immune function and is useful in the treatment of breast, bowel and other metastatic cancers, diabetes, epilepsy, glaucoma, high blood pressure, chronic pain and a host of other medical conditions…

Below is a link to a groundbreaking lecture on the medical benefits of cannabis by University of California-San Francisco oncologist/AIDS specialist Donald Abrams, MD. Abrams contends that smoking cannabis actually reduces your chances of lung cancer, owing to its anti-inflammatory and immune effects.

More: http://open.salon.com/blog/stuartbramhall/2013/08/30/curing_cancer_with_cannabis

Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy?

“Chemotherapy-induced neuropathy (CIPN) has a relevant impact on the quality of life of cancer patients. There are no curative conventional treatments, so further options have to be investigated. We conducted a systematic review in English and Chinese language databases to illuminate the role of medical herbs. 26 relevant studies on 5 single herbs, one extract, one receptor-agonist, and 8 combinations of herbs were identified focusing on the single herbs Acorus calamus rhizoma, Cannabis sativa fructus, Chamomilla matricaria, Ginkgo biloba, Salvia officinalis, Sweet bee venom, Fritillaria cirrhosae bulbus, and the herbal combinations Bu Yang Huan Wu, modified Bu Yang Huan Wu plus Liuwei Di Huang, modified Chai Hu Long Gu Mu Li Wan, Geranii herba plus Aconiti lateralis praeparata radix , Niu Che Sen Qi Wan (Goshajinkigan), Gui Zhi Jia Shu Fu Tang (Keishikajutsubuto), Huang Qi Wu Wu Tang (Ogikeishigomotsuto), and Shao Yao Gan Cao Tang (Shakuyakukanzoto). The knowledge of mechanism of action is still limited, the quality of clinical trials needs further improvement, and studies have not yielded enough evidence to establish a standard practice, but a lot of promising substances have been identified.

While CIPN has multiple mechanisms of neuronal degeneration, a combination of herbs or substances might deal with multiple targets for the aim of neuroprotection or neuroregeneration in CIPN.”

http://www.ncbi.nlm.nih.gov/pubmed/23983777

Texas A&M Pharmacy Researcher Fights Cancer, Pain With New Cannabinoid Receptor Drug

DrDaiLu

“Dr. Lu has been working to find new types of chemotherapeutic drugs that both kill pancreatic cancer and suppress the cancer pain at the same time by targeting a special G-protein coupled receptor that belongs to the biological system responsible for the effects of Tetrahydrocannabinol (THC), a compound derived from some varieties of cannabis (hemp) or made synthetically, that is the primary psychoactive agent in marijuana and hashish.

 Dr. Lu says pancreatic cancer cells have more type 2 cannabinoid receptors than do healthy cells.

 Consequently, drug molecules that selectively activate this receptor can induce cancer cell death without affecting normal pancreatic cells, noting that when given to mice with pancreatic tumors, the molecule prevented tumor growth and suppressed the spread of cancer to healthy organs.

 Meanwhile, this class of compounds also generates painkillers comparable to morphine’s pain killing effect…”

More: http://www.bionews-tx.com/news/2013/08/20/texas-am-pharmacy-researcher-fights-cancer-pain-with-new-cannabinoid-receptor-drug/

Cannabinoids may be a target for new strategies in cancer treatment

“Cannabis-like substances that are produced by the body have both therapeutic and harmful properties, besides their well-known intoxicating effects, and the body’s cannabinoid system may be a target for new strategies in cancer treatment…

Cannabinoids have moreover been shown to affect the fate of cells. Cannabinoids protect some brain cells, whereas cells in certain types of brain tumors, such as glioma, are stimulated to commit controlled cell suicide (apoptosis)…

In summary, the findings of Sofia Gustafsson’s studies show that cannabinoids can be toxic for cancer cells… These findings are important for our knowledge both of the potential of the cannabinoid system as a target system for new strategies in cancer treatment…”

More: http://www.news-medical.net/news/20120229/Cannabinoids-may-be-a-target-for-new-strategies-in-cancer-treatment.aspx

HAL BROWN: Medical marijuana could have eased wife’s pain

“My only direct personal experience with the effectiveness of medical marijuana was when my wife was dying of cancer and was on chemo. Without going deeply into details, her life became a living hell as death became imminent.
 

She was very resistant when a friend tried to persuade her to try some marijuana, which he said he could get from his son (a responsible recreational user with a good job, wife, and family). When her Dana Farber oncologist didn’t tell her NOT to try it (being reluctant to tell her TO try it, let’s call it a wink and an affirmative nod), she agreed.

She did so once, and the results were amazing. She had six full hours where her debilitating symptoms were significantly relieved. The severe persistent nausea which plagued her, despite being on three anti-nausea drugs, disappeared. Even so, she refused to try it again. She toughed it out until the end, which was a brutal four days at Brigham and Women’s, as even the strongest pain medication had no effect.

I have little doubt that eventually the chemicals which can relieve diseases and symptoms will be synthesized, and be approved as prescription medications.

Until then, it seems to me that the good of making medical marijuana available for those who get a doctor’s prescription outweighs the bad.

I think almost everyone who has had a loved one suffer with an illness which makes life unbearable, and for which marijuana would help, would agree with me. We need to deal with drug abuse aggressively in Middleboro; but making sick people pay the price for drug abusers by withholding treatment for people truly in need seems cruel and insensitive.

I urge anyone who disagrees with me to read this article from the American Cancer Society website.”

http://www.enterprisenews.com/newsnow/x1343094540/COMMENTARY-Medical-marijuana-could-have-eased-wife-s-pain

Clinical evaluation and optimal management of cancer cachexia.

“Cancer anorexia-cachexia syndrome (CACS) is a complex metabolic syndrome, different from malnutrition and sarcopenia, which is very common in cancer patients. Treatment for CACS is based on nutritional support and CACS pathophysiology-modulating drugs. The most commonly used are megestrol acetate (MA) and corticosteroids. The efficacy of MA has been confirmed by multiple clinical trials and meta-analyses. Glucocorticoids are also effective but should only be used for short periods and in selected cases. Future strategies should include intensified research into potentially effective drugs (ω-3 fatty acids, thalidomide, cannabinoids, ghrelin, bortezomib, and COX-2 inhibitors), combined treatment and new drugs (anti-IL-6 monoclonal antibodies, melanocortin, β-2 antagonists, and androgen receptor-modulating analogues). We propose a review based on the literature on the pathophysiology of CACS, the diagnostic criteria and treatment, and future strategies.”

http://www.ncbi.nlm.nih.gov/pubmed/23953794